Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -8.34% is 346% below its 5-year average of 3.39%, near the low end of its 5-year range (-8.34%–27.07%).
As of the fiscal period ended Tuesday, June 30, 2026. 2017.72% below its 12-month average of -0.39%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -8.34%.
RETURN ON INVESTED CAPITAL (ROIC)
-8.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-0.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-0.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
3.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
0.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-2017.72%
CURRENT VS 3Y AVG
-3634.31%
CURRENT VS 5Y AVG
-345.82%
CURRENT VS 10Y AVG
-1082.36%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+76.60%
vs the sector median at left
Organogenesis Holdings Inc.
Market Cap
$172.42M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
-0.39%
3Y Avg
-0.22%
5Y Avg
3.39%
Market Cap
$171.13M
Return on Invested Capital (ROIC)
-30.23%
TTM Avg
-28.70%
3Y Avg
-31.34%
5Y Avg
-41.69%
Market Cap
$173.76M
Return on Invested Capital (ROIC)
-42.61%
TTM Avg
-32.20%
3Y Avg
-32.84%
5Y Avg
-32.70%
Market Cap
$174.27M
Return on Invested Capital (ROIC)
-90.33%
TTM Avg
-95.47%
3Y Avg
-83.14%
5Y Avg
-82.51%
Market Cap
$169.53M
Return on Invested Capital (ROIC)
-5.22%
TTM Avg
-22.12%
3Y Avg
-29.09%
5Y Avg
-27.39%
Market Cap
$168.92M
Return on Invested Capital (ROIC)
-58.55%
TTM Avg
-41.33%
3Y Avg
-32.67%
5Y Avg
-48.97%
Market Cap
$168.10M
Return on Invested Capital (ROIC)
-1039.56%
TTM Avg
-137.05%
3Y Avg
-111.74%
5Y Avg
-93.55%
Market Cap
$179.26M
Return on Invested Capital (ROIC)
-3.21%
TTM Avg
-7.29%
3Y Avg
-11.96%
5Y Avg
-13.56%
Market Cap
$165.32M
Return on Invested Capital (ROIC)
4.92%
TTM Avg
-1.65%
3Y Avg
-7.20%
5Y Avg
-5.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Organogenesis Holdings Inc. (ORGO) | $172.42M | -8.34% | -0.39% | -0.22% | 3.39% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | -30.23% | -28.70% | -31.34% | -41.69% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -42.61% | -32.20% | -32.84% | -32.70% |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | -90.33% | -95.47% | -83.14% | -82.51% |
| Journey Medical Corporation (DERM)vs › | $169.53M | -5.22% | -22.12% | -29.09% | -27.39% |
| MediWound Ltd. (MDWD)vs › | $168.92M | -58.55% | -41.33% | -32.67% | -48.97% |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | -1039.56% | -137.05% | -111.74% | -93.55% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | -3.21% | -7.29% | -11.96% | -13.56% |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 4.92% | -1.65% | -7.20% | -5.46% |
| Nkarta, Inc. (NKTX)vs › | $165.27M | -42.11% | -29.16% | -30.37% | -28.38% |
ROIC
-8.3%
ROE
-31.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -8.34% |
| 2026-03-31 | 1.34% |
| 2025-12-31 | 8.52% |
| 2025-09-30 | 0.20% |
| 2025-06-30 | -3.68% |
| 2025-03-31 | -4.38% |
| 2024-12-31 | -0.31% |
| 2024-09-30 | -3.41% |
| 2024-06-30 | -3.02% |
| 2024-03-31 | 1.83% |
| 2023-12-31 | 1.79% |
| 2023-09-30 | 3.61% |
| 2023-06-30 | 2.94% |
| 2023-03-31 | 4.01% |
| 2022-12-31 | 4.51% |
| 2022-09-30 | 9.13% |
| 2022-06-30 | 13.05% |
| 2022-03-31 | 16.59% |
| 2021-12-31 | 20.08% |
| 2021-09-30 | 24.90% |
| 2021-06-30 | 27.07% |
| 2021-03-31 | 20.64% |
| 2020-12-31 | 11.08% |
| 2020-09-30 | 1.93% |
| 2020-06-30 | -17.41% |
| 2020-03-31 | -20.89% |
| 2019-12-31 | -18.32% |
| 2019-09-30 | -27.30% |
| 2019-06-30 | -22.24% |
| 2019-03-31 | -15.94% |
| 2018-12-31 | -8.84% |
| 2018-09-30 | -1.83% |
| 2018-06-30 | -2.02% |
| 2018-03-31 | -1.79% |
| 2017-12-31 | -1.49% |
| 2017-09-30 | -1.01% |
| 2017-06-30 | -0.09% |
| 2017-03-31 | -0.02% |
| 2016-12-31 | 0.05% |
